ClinicalTrials.Veeva

Menu

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Galderma logo

Galderma

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Device: ablative fractional CO2 laser pretreatment
Device: Microneedles pretreatment
Drug: METVIXIA Cream
Other: occlusive bandage

Study type

Interventional

Funder types

Industry

Identifiers

NCT02511145
RD.03.SPR.40221E
2013-003371-35 (EudraCT Number)

Details and patient eligibility

About

Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques.

Full description

At baseline, each mini-zone was selected and randomly assigned to a pretreatment: 3 zones with microneedling Dermaroller®, 3 zones with ablative fractional CO2 Laser, and 3 zones with no pretreatment. After performing pretreatment, MAL cream was applied on the 6 assigned mini-zones for 3 hours incubation. Each condition was tested with and without occlusion. The three mini-zones with no product applied were used to perform biophysics measures.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female of non childbearing potential, who is at least 18 years of age or older at screening visit.
  • The subject has a skin phototype of I to III on Fitzpatrick's scale (Fitzpatrick et al., 1993) at screening visit.
  • Subject should have 9 mini zone areas on the back that will be able to receive pre-treatments according to protocol. (checked at Screening visit, and assigned at Baseline visit)
  • Female of non childbearing potential (postmenopausal [absence of menstrual bleeding for 1 year prior to screening visit, without any other medical reason], hysterectomy or bilateral oophorectomy).

Exclusion criteria

  • Subject with porphyria,
  • Subject with past history of skin cancer, or current clinical diagnosis of other skin disease (including non-melanoma skin cancer), or tattoos, or cheloid and hypertrophic scars on the test zones, which, in the opinion of the investigator, might interfere with the interpretation of the clinical results,
  • Any uncontrolled or serious disease, or any medical or surgical condition, that may either interfere with the interpretation of the clinical trial results, and/or put the subject at significant risk (according to Investigator's judgment) if he/she participates in the clinical trial.
  • Known or suspected allergies or sensitivities to any components of any of the study drugs (see Product label).
  • The subject has received, applied or taken some specific treatments within specified time frame prior to the baseline visit

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 9 patient groups

Microneedles pretreatment and Metvixia
Active Comparator group
Description:
minizone with Microneedles pretreatment and Metvixia cream application
Treatment:
Drug: METVIXIA Cream
Device: Microneedles pretreatment
Microneedles pretreatment and Metvixia under occlusion
Active Comparator group
Description:
minizone with Microneedles pretreatment and Metvixia cream application with occlusion
Treatment:
Other: occlusive bandage
Drug: METVIXIA Cream
Device: Microneedles pretreatment
Laser pretreatment and Metvixia
Active Comparator group
Description:
minizone with laser pretreatment and Metvixia cream application
Treatment:
Drug: METVIXIA Cream
Device: ablative fractional CO2 laser pretreatment
Laser pretreatment and Metvixia under occlusion
Active Comparator group
Description:
minizone with Laser pretreatment and Metvixia cream application with occlusion
Treatment:
Other: occlusive bandage
Drug: METVIXIA Cream
Device: ablative fractional CO2 laser pretreatment
Metvixia
Active Comparator group
Description:
minizone with Metvixia cream application, without pretreatment
Treatment:
Drug: METVIXIA Cream
Metvixia under occlusion
Active Comparator group
Description:
minizone with Metvixia cream application under occlusion, without pretreatment
Treatment:
Other: occlusive bandage
Drug: METVIXIA Cream
Microneedles pretreatment only
Experimental group
Description:
minizone with Microneedles pretreatment only
Treatment:
Device: Microneedles pretreatment
Laser pretreatment only
Experimental group
Description:
minizone with Laser pretreatment only
Treatment:
Device: ablative fractional CO2 laser pretreatment
Normal skin
No Intervention group
Description:
Normal skin control mini-zone

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems